Vital Farms
Vital Farms' revenue rose 25.3% to $759 million in fiscal 2025. Its operating margin was 11.6%, up from 10.5% a year earlier. Free cash flow was −$48 million, against $36 million a year earlier. The diluted share count rose 2.0%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Vital Farms does
Vital Farms sells eggs and butter. Its eggs come from hens on small farms that it says meet its animal welfare standards, and it sells them under its own brand. It was founded in 2007 on a small plot of land in Austin, Texas, with its first sales at farmers markets and restaurants, and Whole Foods Market began carrying its eggs less than a year later.
The company does not run most of the farms itself. It works with a network of more than 600 small farms and does much of the processing, such as washing and packing, in its own facilities, including its Egg Central Station facility in Missouri. Shell eggs make up the vast majority of its net revenue.
Vital Farms is a Delaware public benefit corporation and a Certified B Corporation. It calls its workers crew members.
Its biggest risks, as it describes them
- Shell eggs make up the vast majority of its revenue, so lower egg sales would hurt it.
- Much of its egg processing happens at one facility in Missouri, where damage could cause disruption.
- Needing to expand its processing and production capacity as it grows.
- Possible trouble keeping or growing its profitability.
- Needing more financing, and loan terms that limit what it can do.
Income statement
From fiscal 2018 to 2025, earnings per share grew 36.9% a year and net income 41.6% a year, as new shares raised the share count by 30% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 31 | 13 | 84 | 151 | 49 |
| Debt incl. finance leases | — | — | — | — | — |
| Net debt (negative means net cash) | — | — | — | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | — | — | — | — | — |
| Interest coverage | 1.0x | 18.5x | 42.5x | 62.9x | 101.1x |
| Current ratio | 3.7x | 3.1x | 3.0x | 3.1x | 2.2x |
| Quick ratio | 3.4x | 2.6x | 2.5x | 2.8x | 1.6x |
Cash flow
Projections
Project Vital Farms' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, 12 insiders bought $612,568 of Vital Farms shares on the open market, and 2 insiders sold $4.2 million, all of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Matthew Ohayer10% owner | Sold plan | 23,250 | $9.56 | $222,270 | Form 4 |
| Nov 9, 2026 | Matthew Ohayer10% owner | Sold plan | 66,200 | $9.68 | $640,816 | Form 4 |
| Nov 6, 2026 | Matthew Ohayer10% owner | Sold plan | 3,550 | $9.53 | $33,832 | Form 4 |
| May 19, 2026 | Hoven Reena Chauhan VanChief People Officer | Bought | 2,242 | $8.92 | $19,999 | Form 4 |
| May 18, 2026 | Glenda J FlanaganDirector | Bought | 6,100 | $8.33 | $50,813 | Form 4 |
| May 15, 2026 | Stephanie CoonChief Strategy Officer | Bought | 5,895 | $8.42 | $49,636 | Form 4 |
| May 15, 2026 | Kofi Owusu Amoo-GottfriedDirector | Bought | 2,375 | $8.45 | $20,069 | Form 4 |
| May 14, 2026 | Joseph Michael HollandChief Supply Chain Officer | Bought | 12,484 | $8.00 | $99,872 | Form 4 |
| May 14, 2026 | William B. CyrDirector | Bought | 6,000 | $8.52 | $51,120 | Form 4 |
| May 14, 2026 | Peter Nicholas PappasCSO and President, Eggs | Bought | 3,500 | $8.51 | $29,785 | Form 4 |
| May 14, 2026 | Kelly J. KennedyDirector | Bought | 2,500 | $8.40 | $21,000 | Form 4 |
| May 14, 2026 | Kathryn McKeonCMO and GM, Butter | Bought | 604 | $8.28 | $5,001 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 38.7% | 34.5% | 18.9% |
| Altman Z'' | 6.72 | 8.14 | 6.07 |
| Accruals ratio | −10.3% | −3.6% | 7.4% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Fail |
| Debt fell relative to assets | — | — | — |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Pass | Pass | Fail |
| F-score | — | — | — |
Compare
Put Vital Farms side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Vital Farms | FY25 | 25.3% | 11.6% | −6.3% | — | — | — | |
| Tootsie Roll Industries | FY25 | 1.3% | 13.8% | 13.2% | — | — | — | Compare |
| Freshpet | FY25 | 13.0% | 6.9% | 1.1% | 5.9% | 0.9x | 8 | Compare |
| John B. Sanfilippo & Son | FY26 | 6.2% | 7.6% | 3.0% | 16.6% | 0.4x | 3 | Compare |
| Westrock Coffee | FY25 | 39.8% | −3.8% | −9.1% | −7.2% | 46.0x | 3 | Compare |
8 years of figures
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 107 | 141 | 214 | 261 | 362 | 472 | 606 | 759 |
| Revenue growth | — | 31.9% | 52.3% | 21.8% | 38.8% | 30.3% | 28.5% | 25.3% |
| Gross profit | 35 | 43 | 74 | 83 | 109 | 162 | 230 | 286 |
| Research and development | — | — | — | — | — | — | — | — |
| Operating income | 7 | 3 | 12 | 0 | 2 | 33 | 64 | 88 |
| Net income | 6 | 2 | 9 | 2 | 1 | 26 | 53 | 66 |
| Diluted EPS (US$) | 0.16 | 0.07 | 0.27 | 0.06 | 0.03 | 0.59 | 1.18 | 1.44 |
| Diluted shares (millions) | 35 | 36 | 33 | 43 | 44 | 43 | 45 | 46 |
| Cash flow | ||||||||
| Cash from operations | 11 | −5 | 12 | 18 | −8 | 51 | 65 | 34 |
| Capital expenditure | 2 | 5 | 10 | 17 | 10 | 12 | 29 | 82 |
| Free cash flow | 9 | −10 | 1 | 1 | −19 | 39 | 36 | −48 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 1 | 1 | 2 | 4 | 6 | 7 | 10 | 12 |
| Balance sheet at fiscal year end | ||||||||
| Cash and short-term investments | — | 1 | 30 | 31 | 13 | 84 | 151 | 49 |
| Debt incl. finance leases | — | 5 | 1 | — | — | — | — | — |
| Total assets | — | 62 | 171 | 190 | 215 | 275 | 359 | 519 |
| Total liabilities | — | 30 | 29 | 38 | 56 | 82 | 90 | 168 |
| Shareholders' equity | 4 | 9 | 142 | 152 | 158 | 193 | 269 | 351 |
| Margins and ratios | ||||||||
| Gross margin | 32.6% | 30.5% | 34.8% | 31.8% | 30.2% | 34.4% | 37.9% | 37.6% |
| Operating margin | 6.3% | 2.4% | 5.7% | 0.0% | 0.6% | 7.0% | 10.5% | 11.6% |
| Net margin | 5.4% | 1.7% | 4.1% | 0.9% | 0.3% | 5.4% | 8.8% | 8.7% |
| Free cash flow margin | 8.9% | −7.2% | 0.6% | 0.4% | −5.1% | 8.3% | 6.0% | −6.3% |
| Rule of 40 (growth + FCF margin) | — | 24.7% | 52.8% | 22.1% | 33.6% | 38.7% | 34.5% | 18.9% |
| Return on capital | — | — | 14.8% | — | — | — | — | — |
| Return on equity | — | — | 11.7% | 1.6% | 0.8% | 14.6% | 23.1% | 21.4% |
| Return on assets | — | — | 7.5% | 1.3% | 0.6% | 10.4% | 16.8% | 15.1% |
| Net debt to EBITDA | — | 0.7x | −1.9x | — | — | — | — | — |